000 01301 a2200361 4500
005 20250513165341.0
264 0 _c19990311
008 199903s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/S0140-6736(98)05202-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKelly, J P
245 0 0 _aMajor upper gastrointestinal bleeding and the use of calcium channel blockers.
_h[electronic resource]
260 _bLancet (London, England)
_cFeb 1999
300 _a559 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAspirin
_xtherapeutic use
650 0 4 _aCalcium Channel Blockers
_xadverse effects
650 0 4 _aCase-Control Studies
650 0 4 _aGastrointestinal Hemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aHungary
_xepidemiology
650 0 4 _aMassachusetts
_xepidemiology
650 0 4 _aMultivariate Analysis
650 0 4 _aRisk Factors
650 0 4 _aSweden
_xepidemiology
700 1 _aLaszlo, A
700 1 _aKaufman, D W
700 1 _aSundstrom, A
700 1 _aShapiro, S
773 0 _tLancet (London, England)
_gvol. 353
_gno. 9152
_gp. 559
856 4 0 _uhttps://doi.org/10.1016/S0140-6736(98)05202-7
_zAvailable from publisher's website
999 _c9990264
_d9990264